A nurse is leading a group of clients who have anxiety disorders. Which of the following actions should the nurse take during the working phase of therapy?

A. Discuss the provider's goals for the client's care:
Discussing the provider's goals is essential, but it may not directly address the client's concerns about medication adherence. While these goals are important for the overall care plan, it's crucial to first engage in a conversation with the client about their specific issues and challenges related to taking the prescribed medication. The client's perspective and concerns should be a priority.

B. Ask the client if the medication is causing adverse effects:
This is the recommended choice. Inquiring about adverse effects is important to understand the client's experience with the medication. Some clients may discontinue their medication due to intolerable side effects. By addressing this concern, the nurse can provide education, seek potential solutions, and collaborate with the healthcare team to adjust the medication or dosage. Open communication helps to identify and mitigate barriers to medication adherence.

C. Tell the client they will be admitted to an inpatient care facility if they do not take the medication:
This choice involves a coercive and threatening approach. It's not an ethical or therapeutic method to promote medication adherence. Threatening involuntary hospitalization can create fear and mistrust, potentially leading to further non-compliance and damaging the therapeutic relationship. It should be avoided.

D. Request the provider prescribe a second antipsychotic medication to the client:
This option is not appropriate at this stage. Adding another medication without addressing the underlying issue of non-adherence and without assessing the client's response to the current medication is not advisable. It can complicate the medication regimen, potentially worsen side effects, and doesn't address the primary concern, which is the client's non-adherence to their current medication. It's important to understand the reasons for non-adherence before considering additional medications.

A. Aspartate aminotransferase 20 units/L:
This result indicates the level of an enzyme in the blood. A value of 20 units/L is within the normal range (usually 10-40 units/L). Aspartate aminotransferase (AST) is an enzyme found in the liver, heart, muscles, and other tissues. Elevated levels might indicate liver damage, but 20 units/L is a normal value.

B. Platelets 250,000/mm3:
Platelets are components of blood that help with clotting. A value of 250,000/mm3 is within the normal range (normal range is typically 150,000 to 450,000/mm3). Normal platelet levels are crucial for preventing excessive bleeding or clotting.

C. Sodium 140 mEq/L:
Sodium is an electrolyte essential for maintaining the body's water balance and nerve function. A level of 140 mEq/L falls within the normal range (typically 135-145 mEq/L). Proper sodium levels are important for overall body functioning.

D. Fasting glucose 175 mg/dL:
This indicates the concentration of glucose (sugar) in the blood after a period of fasting. A level of 175 mg/dL is elevated. Fasting glucose levels above 125 mg/dL may suggest diabetes or prediabetes. Elevated glucose levels are a cause for concern as they indicate poor blood sugar regulation, which can lead to various health complications, including diabetes.